Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT05962073
Other study ID # PreoxyEIT
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date July 30, 2024

Study information

Verified date April 2024
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hypoxemia during endotracheal intubation is one of this procedure's most frequent and severe complications, which can lead to cardiac arrest and other adverse outcomes. Although various studies have been conducted to ensure the safety of endotracheal intubation, most of them have focused on the physiological changes during the procedure in surgical settings, where general anesthesia is administered to healthy subjects. However, the physiological characteristics of critically ill patients who require endotracheal intubation in the intensive care unit (ICU) may differ from those of healthy subjects. When comparing the oxygen saturation-dissociation curve of healthy subjects and critically ill patients, the latter show a steeper decline in oxygen saturation (SpO2) below 90% when hypoxemia occurs. Clinically, it is difficult to maintain or recover oxygen saturation when it drops. Therefore, preoxygenation is also essential for critically ill patients with a relatively small lung reservoir, as it can help maintain higher and longer oxygen saturation during endotracheal intubation. For this reason, apneic oxygenation was proposed in the 1950s as a method of oxygen delivery during general anesthesia for surgery, and clinical randomized controlled trials (RCTs) applying it to critically ill patients in the ICU have been conducted since 20 years ago. In an observational study by Macamn et al., the adjusted odds ratio (OR) of a bag valve mask was 1, while that of a high-flow nasal cannula (HFNC) was 5.75 and that of non-invasive ventilation (NIV) was 0.10 when different preoxygenation methods were used. n FLORARI 2, a large-scale clinical RCT comparing NIV and HFNC with or without apneic oxygenation, NIV was significantly more effective than HFNC in reducing severe hypoxemia. Based on these previous studies, the investigators can infer that supplying oxygen during laryngoscopy is not very effective in preventing hypoxemia in critically ill patients. However, there is no guideline on which device to choose for preoxygenation in the ICU, and NIV or HFNC are selected according to the operator's preference. This is because few studies have examined the physiological effects of these devices on patients. Therefore, in this study, the investigators aim to compare the clinical outcomes and adverse events of NIV and HFNC as preoxygenation methods for endotracheal intubation in critically ill patients with acute respiratory failure and to evaluate their physiological effects using electrical impedance tomography.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date July 30, 2024
Est. primary completion date February 28, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients aged 18 or older - Acute respiratory failure is defined as follows: Tachypnea over 30 breaths/minute / Symptoms or signs of respiratory failure / PaO2/FiO2 less than 300 - When there is an indication for endotracheal intubation for mechanical ventilation - When sufficient information and a consent form for the study are obtained from the patient or the patient's guardian Exclusion Criteria: - Coma with Glasgow score < 8 - Endotracheal intubation during CPR - Contraindications for NIV: poor patient cooperation, recurrent vomiting, GI bleeding, severe craniofacial injury, upper airway obstruction, etc. - Contraindications for RSI: complete upper airway obstruction, severe trauma obscuring cervical structures, etc. - Implanted electronic medical devices (defibrillator, pacemaker or spinal cord stimulator) - Skin damage or inadequate electrode contact due to wound dressing at the electrode site - BMI > 50 - Polydipsia - Unmeasurable SpO2 - Pregnancy or lactation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
HFNC
High-flow oxygen therapy before intubation for preoxygenation

Locations

Country Name City State
Korea, Republic of Samsung Medical Center Seoul Gangnam

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lowest SpO2 Minimum SpO2 value during endotracheal intubation at day1(before, during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
Secondary EIT measurement Change of T2-T1 at day1(before, during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
Secondary EIT measurement Change of ?EILI at day1(before, during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
Secondary EIT measurement Change of ?EELI at day1(before, during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
Secondary EIT measurement Change of Overdistension at day1(before, during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
Secondary EIT measurement Change of Collapse at day1(before, during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
Secondary EIT measurement Change of Global Inhomogeneity Index at day1(before, during and after preoxygenation and at 5 minutes and at 30 minutes after intubation)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06007495 - Pilot Physiological Evaluation of an Investigational Mask With Expiratory Washout. N/A
Completed NCT05060926 - Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning
Recruiting NCT05203536 - Respiratory Mechanics Assessment During Assisted Mechanical Ventilation
Completed NCT04570384 - Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 Phase 2
Not yet recruiting NCT05499039 - High Flow Nasal Cannula Versus Non-Invasive (NIV)in Both Hypoxemic and Hypercapnic Respiratory Failure. N/A
Completed NCT04568642 - Comparing Closed-loop FiO2 Controller With Conventional Control of FiO2 N/A
Completed NCT03653806 - Automated Analysis of EIT Data for PEEP Setting
Completed NCT01747109 - Benefits of Optiflow® Device for Preoxygenation Before Intubation in Acute Hypoxemic Respiratory Failure : The PREOXYFLOW Study N/A
Terminated NCT04632043 - Early Versus Delayed Intubation of Patients With COVID-19 N/A
Completed NCT04581811 - Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) N/A
Not yet recruiting NCT06064409 - Optimal Timing and Failure Prediction of High Flow Nasal Cannula Oxygen Therapy in Emergency Department: Prospective Observational Single Center Study
Completed NCT03133520 - Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure N/A
Not yet recruiting NCT06438198 - Early Switch From Controlled to Assisted Ventilation N/A
Recruiting NCT04997265 - Strategies for Anticoagulation During Venovenous ECMO N/A
Completed NCT05083130 - Awake Prone Positioning in Moderate to Severe COVID-19 N/A
Active, not recruiting NCT06374589 - Closed-Loop O2 Use During High Flow Oxygen Treatment Of Critical Care Adult Patients (CLOUDHFOT) N/A
Active, not recruiting NCT06333002 - Machine Learning Model to Predict Outcome and Duration of Mechanical Ventilation in Acute Hypoxemic Respiratory Failure
Recruiting NCT05078034 - HNFO With or Without Helmet NIV for Oxygenation Support in Acute Respiratory Failure Pilot RCT N/A
Recruiting NCT03513809 - Inflammation and Distribution of Pulmonary Ventilation Before and After Tracheal Intubation in ARDS Patients
Terminated NCT04395807 - Helmet CPAP Versus HFNC in COVID-19 N/A